4
Changes in Ownership
Grace Therapeutics, Inc. Filed Acc 0001171843-22-004514
Options or other derivatives
- PRESIDENT & CEO acquired 560,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| D'Alvise Janelle PRESIDENT & CEO | 2022-06-22 | Grant or award · Stock Options (Right to Buy) | +560,000 | 560,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…